SAVIMS

SAVIMS logo white
Menu

October 2022

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Case Report on Encephalitis and Myocarditis Post-COVID-19 Vaccination

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Mörz, M. (2022). A case report: Multifocal necrotizing encephalitis and myocarditis after BNT162b2 mRNA vaccination against COVID-19. Vaccines, 10(10), 1651. https://doi.org/10.3390/vaccines10101651 Summary: This case report details a 76-year-old man with Parkinson’s disease who died three weeks after his third COVID-19 vaccination. Despite a clinical diagnosis of aspiration pneumonia, autopsy revealed unexpected acute vasculitis and […]

COVID-19, Covid-19 vaccines, Other scientific evidence, Treatment, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

COVID-19 Vaccine Safety Monitoring: FDA Insights

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Treatment, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Anderson, S. (2020). CBER plans for monitoring COVID-19 vaccine safety and effectiveness. Vaccine and Related Biological Products Advisory Committee Meeting Presentation, October 22. FDA. Summary: The FDA’s Vaccines and Related Biological Products Advisory Committee meeting on October 22, 2020, provided insights into the agency’s plans for monitoring the safety and effectiveness of COVID-19 vaccines.

Scroll to Top